We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Implantable Bluetooth Pacemaker Streamlines Remote Monitoring

By HospiMedica International staff writers
Posted on 24 Jan 2022
Image: The Alizea pacemaker with Bluetooth connectivity (Photo courtesy of MicroPort CRM)
Image: The Alizea pacemaker with Bluetooth connectivity (Photo courtesy of MicroPort CRM)
A novel pacemaker that pairs to a home monitor provides timely automated alerts and patient triggered warnings when symptomatic.

The MicroPort CRM (Clamart, France) Alizea Bluetooth Pacemaker is cardiac rhythm management (CRM) device with two sensors (an accelerometer and a minute ventilation sensor) that adapt the physiologic response to suit patient activity. The two sensors continually cross-check each other, preventing unnecessary rate increases due to artifacts. Features include SafeR, an AV node management solution that reduces ventricular pacing while managing long PR intervals; SAM, a sleep apnea monitoring tool; and AutoMRI mode, which detects an MRI field and automatically switches to asynchronous mode.

Alizea connects via Bluetooth to SmartView Connect, a home remote monitoring system that offers patient monitoring and follow-up, timely alerts and detailed reports on the patient, removing the need for hospital-based routine examinations and reducing burden on the healthcare system. It also offers customizable alerts, including alerts that oversee system integrity, ensuring the pacemaker’s continuous function; alerts that indicate potential dislodgement or lead fracture; and notifications of post-MRI device function.

“We successfully launched Alizea in Europe in June 2021, and Japan is the second region to benefit from its advanced technological functions,” said Benoît Clinchamps, President of MicroPort CRM, on the occasion of regulatory approval of the Alizea in Japan. “As part of our commitment to improve the lives of as many patients as possible, and to support healthcare professionals in their mission, we will continue to deploy Alizea and Smartview Connect around the world.”

“Around 64,000 patients are implanted with a pacemaker each year in Japan, and coupled with the difficulties that have arisen from the current health crisis, there is a growing need to monitor patients remotely, without them having to travel,” said Noboru Shimizu, VP of MicroPort CRM sales in Japan. “Thanks to Alizea pacemakers and its SmartView Connect monitor, we are positioning ourselves in the Japanese market with the very best in cardiac pacing. I am convinced that this will allow us to strengthen our presence in Japan.”

Within the right atrium of the heart is a natural pacemaker that sends an electrical stimulus that travels from the pacemaker (the SA node) to the ventricles (the AV node). In the presence of an AV block, the transfer of the electrical nerve conduction that regulates the normal, rhythmic, pumping action of the heart muscle is interrupted or slowed.

Related Links:
MicroPort

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Measuring Rod
seca 233
New
VTE Prevention System
Flowtron ACS900

Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more